171 results
Page 6 of 9
8-K
EX-10.4
mopqdvuo1z 7u9u
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
v73526it
6 May 19
Adaptimmune TRANSFORMING T CELL THERAPY Clinical and Business Update
8:11am
8-K
EX-99.1
3pvla
6 May 19
Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors
7:08am
8-K/A
EX-99.1
krlmn27q25k4
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
7p8po7w3 jjrq
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
l94q ni46d284
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
S-3ASR
EX-23.2
fe0z9eizknfct
12 Jul 18
Automatic shelf registration
4:30pm
S-3ASR
fuk0wx6cr82y8mvk
12 Jul 18
Automatic shelf registration
4:30pm
8-K
yunooejw1gta5h9aja
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
7kdwbwy
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
d7hjs
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am